Intrathecal Corticoids in Permanent Focal Cerebral Ischemia in Rats. Part I: a New Therapeutic Approach in the Acute Phase

Overview

Journal J Cereb Blood Flow Metab

Publisher Sage Publications

Specialties Cardiology & Vascular Diseases
Endocrinology
Neurology

Date 2009 Nov 12

PMID 19904284

Citations 4

Authors

Sophia L Goericke

Tobias Engelhorn

Michael Forsting

Ulrich Speck

Stefan Maderwald

Mark E Ladd

Arnd Doerfler

Affiliations

Soon will be listed here.

Abstract

Intrathecally, triamcinolone acetonide (TCA) was suggested to have neuroprotective efficacy on infarction volume in acute focal cerebral ischemia in rats. In the first dose-finding study, TCA in five different doses or saline was administered into the cisterna magna of 12 rats, each 30 mins after endovascular occlusion of the middle cerebral artery (MCAO). In the second magnet resonance controlled confirmation study, the most neuroprotective dose was compared with controls in each of the 15 rats. Infarction volume was calculated at 24 h by 2.3.5 triphenyl-tetrazolium-chloride staining. Compared with controls (18.2%), infarction volume was significantly reduced using TCA at a dose of 0.012 mg/kg body weight (BW) (13.4%, P=0.04). TCA at doses of 0.03 (17.7%, P=0.84), 0.006 (15.9%, P=0.24), and 0.003 mg/kg BW (14.5%, P=0.11) did not significantly reduce infarction size. TCA 0.3 mg/kg BW resulted in bilateral infarction with increased infarction volume (19.8%, P=0.49). Magnetic resonance imaging confirmed successful MCAO and intrathecal administration. In experiment 2 compared with controls (20.0%), infarction volume was significantly reduced using TCA 0.012 mg/kg (13.4%, P=0.02). Intrathecally, TCA may significantly reduce infarction volume in acute focal cerebral ischemia in rats. Further studies are necessary to define the value of this therapy.

Citing Articles

Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells.

Pitarokoili K, Sgodzai M, Gruter T, Bachir H, Motte J, Ambrosius B J Neuroinflammation. 2019; 16(1):58.

PMID: 30851725 PMC: 6408772. DOI: 10.1186/s12974-019-1445-0.

Treatment of acute cerebral ischemia using animal models: a meta-analysis.

Wang P, Zhou Y, Fang H, Lin S, Wang Y, Liu Y Transl Neurosci. 2017; 6(1):47-58.

PMID: 28123790 PMC: 4936615. DOI: 10.1515/tnsci-2015-0006.

Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation.

Varvarousi G, Stefaniotou A, Varvaroussis D, Xanthos T Cardiovasc Drugs Ther. 2014; 28(5):477-88.

PMID: 25163464 PMC: 4163188. DOI: 10.1007/s10557-014-6547-4.

The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice.

Gelderblom M, Leypoldt F, Lewerenz J, Birkenmayer G, Orozco D, Ludewig P J Cereb Blood Flow Metab. 2012; 32(5):835-43.

PMID: 22234339 PMC: 3345911. DOI: 10.1038/jcbfm.2011.189.

References

Hoffmann V, Schimrigk S, Islamova S, Hellwig K, Lukas C, Brune N . Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients. J Neurol Sci. 2003; 211(1-2):81-4. DOI: 10.1016/s0022-510x(03)00060-1. View

Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H . Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest. 2009; 119(6):1477-88. PMC: 2689117. DOI: 10.1172/JCI37413. View

Akdemir G, Ergungor M, Sezer M, Albayrak L, Daglioglu E, Kilinc K . Therapeutic efficacy of intraventricular cyclosporine A and methylprednisolone on a global cerebral ischemia model in rats. Neurol Res. 2005; 27(8):827-34. DOI: 10.1179/016164105X63610. View

Norris J, Hachinski V . High dose steroid treatment in cerebral infarction. Br Med J (Clin Res Ed). 1986; 292(6512):21-3. PMC: 1338973. DOI: 10.1136/bmj.292.6512.21. View

Kagansky N, Levy S, Knobler H . The role of hyperglycemia in acute stroke. Arch Neurol. 2001; 58(8):1209-12. DOI: 10.1001/archneur.58.8.1209. View

PATTEN B, Mendell J, Bruun B, Curtin W, Carter S . Double-blind study of the effects of dexamethasone on acute stroke. Neurology. 1972; 22(4):377-83. DOI: 10.1212/wnl.22.4.377. View

Limbourg F, Huang Z, Plumier J, Simoncini T, Fujioka M, Tuckermann J . Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest. 2002; 110(11):1729-38. PMC: 151626. DOI: 10.1172/JCI15481. View

Bessler H, Mendel C, Straussberg R, Gurary N, Aloni D, Sirota L . Effects of dexamethasone on IL-1beta, IL-6, and TNF-alpha production by mononuclear cells of newborns and adults. Biol Neonate. 1999; 75(4):225-33. DOI: 10.1159/000014099. View

Slivka A, Murphy E . High-dose methylprednisolone treatment in experimental focal cerebral ischemia. Exp Neurol. 2001; 167(1):166-72. DOI: 10.1006/exnr.2000.7532. View

10.

. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

11.

de Courten-Myers G, Kleinholz M, Wagner K, Xi G, Myers R . Efficacious experimental stroke treatment with high-dose methylprednisolone. Stroke. 1994; 25(2):487-92; discussion 493. DOI: 10.1161/01.str.25.2.487. View

12.

Ziylan Y, Lefauconnier J, Bernard G, Bourre J . Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier. J Neurochem. 1988; 51(5):1338-42. DOI: 10.1111/j.1471-4159.1988.tb01094.x. View

13.

Lapchak P, Chapman D, Nunez S, Zivin J . Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: possible involvement of GABA(A) receptors. Stroke. 2000; 31(8):1953-6; discussion 1957. DOI: 10.1161/01.str.31.8.1953. View

14.

Broderick J, Hacke W . Treatment of acute ischemic stroke: Part II: neuroprotection and medical management. Circulation. 2002; 106(13):1736-40. DOI: 10.1161/01.cir.0000030407.10591.35. View

15.

Tuor U, Simone C, Barks J, Post M . Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke. 1993; 24(3):452-7. DOI: 10.1161/01.str.24.3.452. View

16.

Williams L, Rotich J, Qi R, Fineberg N, Espay A, Bruno A . Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002; 59(1):67-71. DOI: 10.1212/wnl.59.1.67. View

17.

Skjoeth J, Bjerre P . Effect of glucocorticoids on ICP in patients with a cerebral tumour. Acta Neurol Scand. 1997; 96(3):167-70. DOI: 10.1111/j.1600-0404.1997.tb00261.x. View

18.

Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

19.

Betz A, Coester H . Effect of steroids on edema and sodium uptake of the brain during focal ischemia in rats. Stroke. 1990; 21(8):1199-204. DOI: 10.1161/01.str.21.8.1199. View

20.

Ayata C, Ropper A . Ischaemic brain oedema. J Clin Neurosci. 2002; 9(2):113-24. DOI: 10.1054/jocn.2001.1031. View